Chasing Biogen, AveXis posts improved gene therapy data – FierceBiotech
FierceBiotech |
Chasing Biogen, AveXis posts improved gene therapy data
FierceBiotech AveXis has posted an update on the spinal muscular atrophy (SMA) patients treated with its gene therapy. The latest data show an uptick in the proportion of patients able to sit unassisted and talk, fueling AveXis' hopes of establishing AVXS-101 as a … AveXis to Report Third Quarter 2017 Financial and Operating Results |
